methanol has been researched along with Infections, Staphylococcal in 19 studies
Methanol: A colorless, flammable liquid used in the manufacture of FORMALDEHYDE and ACETIC ACID, in chemical synthesis, antifreeze, and as a solvent. Ingestion of methanol is toxic and may cause blindness.
primary alcohol : A primary alcohol is a compound in which a hydroxy group, -OH, is attached to a saturated carbon atom which has either three hydrogen atoms attached to it or only one other carbon atom and two hydrogen atoms attached to it.
methanol : The primary alcohol that is the simplest aliphatic alcohol, comprising a methyl and an alcohol group.
Excerpt | Relevance | Reference |
---|---|---|
"Small quantities of the non-toxic residue of phenol-killed, acetone-washed, and methanol-extracted tubercle bacilli of the BCG strain conferred a high degree of resistance on mice against otherwise lethal experimental infection with Klebsiella pneumoniae and with a number of other pathogenic bacteria." | 3.64 | STUDIES ON THE HETEROLOGOUS IMMUNOGENICITY OF A MENTHANOL-INSOLUBLE FRACTION OF ATTENUATED TUBERCLE BACILLI (BCG). I. ANTIMICROBIAL PROTECTION. ( BONHAG, RS; PARKS, JA; WEISS, DW, 1964) |
"Since intracranial retained wooden foreign bodies frequently cause delayed complications of severe central nervous system infection, surgical removal is necessary even in the absence of symptoms." | 2.42 | A case of delayed brain abscess due to a retained intracranial wooden foreign body: a case report and review of the last 20 years. ( Endo, S; Hamada, H; Hayashi, N; Hirashima, Y; Nishio, Y, 2004) |
"The surface area of the excision wounds was monitored planimetrically every four (4) days until a complete wound closure or healing took place." | 1.37 | Wound healing potential of methanol extract of Spathodea campanulata stem bark formulated into a topical preparation. ( Bayor, MT; Kwapong, AA; Ofori-Kwakye, K, 2011) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (36.84) | 18.7374 |
1990's | 1 (5.26) | 18.2507 |
2000's | 3 (15.79) | 29.6817 |
2010's | 4 (21.05) | 24.3611 |
2020's | 4 (21.05) | 2.80 |
Authors | Studies |
---|---|
Alhazmi, A | 1 |
Aldairi, AF | 1 |
Alghamdi, A | 2 |
Alomery, A | 1 |
Mujalli, A | 1 |
Obaid, AA | 1 |
Farrash, WF | 1 |
Allahyani, M | 1 |
Halawani, I | 1 |
Aljuaid, A | 1 |
Alharbi, SA | 1 |
Almehmadi, M | 1 |
Alharbi, MS | 1 |
Khan, AA | 1 |
Jastaniah, MA | 1 |
Sannat, C | 1 |
Hirpurkar, SD | 1 |
Shakya, S | 1 |
Dutta, GK | 1 |
Roy, M | 1 |
Jolhe, DK | 1 |
Singh, J | 1 |
Patyal, A | 1 |
Rawat, N | 1 |
Gade, NE | 1 |
Tripathi, SM | 1 |
Kalim, MO | 1 |
S Al-Hazmi, A | 1 |
M Albeshi, B | 1 |
M Alsofyani, E | 1 |
Alherthi, MN | 1 |
Aljuaid, MM | 1 |
Alfifi, OA | 1 |
Alshaer, RS | 1 |
Alsaadi, RS | 1 |
M Alomery, A | 1 |
Almehmadi, MM | 1 |
Eid, E | 1 |
Hawash, YA | 1 |
Noumi, E | 1 |
Snoussi, M | 1 |
Merghni, A | 1 |
Nazzaro, F | 1 |
Quindós, G | 1 |
Akdamar, G | 1 |
Mastouri, M | 1 |
Al-Sieni, A | 1 |
Ceylan, O | 1 |
Liu, B | 1 |
Wang, M | 1 |
Wang, X | 1 |
Anas, K | 1 |
Jayasree, PR | 1 |
Vijayakumar, T | 1 |
Manish Kumar, PR | 1 |
Ofori-Kwakye, K | 1 |
Kwapong, AA | 1 |
Bayor, MT | 1 |
WEISS, DW | 1 |
BONHAG, RS | 1 |
PARKS, JA | 1 |
Navarro, V | 1 |
Villarreal, ML | 1 |
Rojas, G | 1 |
Lozoya, X | 1 |
Sher, NA | 1 |
Chaparas, SD | 1 |
Greenberg, LE | 1 |
Bernard, S | 1 |
Ashbel', SI | 1 |
Bykova, NP | 1 |
Dubkova, TS | 1 |
Kupriianov, VA | 1 |
Kupriianova, TS | 1 |
Gondokesumo, ME | 1 |
Kurniawan, IM | 1 |
Ferguson, DD | 1 |
Smith, TC | 1 |
Donham, KJ | 1 |
Hoff, SJ | 1 |
KJEMS, E | 1 |
RAYNAUD, M | 2 |
KAYSER, A | 2 |
HAUKENES, G | 1 |
Nishio, Y | 1 |
Hayashi, N | 1 |
Hamada, H | 1 |
Hirashima, Y | 1 |
Endo, S | 1 |
Kiel, R | 1 |
Wiaux, C | 1 |
Atipo-Tsiba, PW | 1 |
Gottrau, Pd | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Bacillus Calmette-Guerin Against Covid-19 for Prevention and Amelioration of Severity Trial[NCT04534803] | Phase 3 | 0 participants (Actual) | Interventional | 2021-09-30 | Withdrawn (stopped due to At this time it has been decided by the study team the the study will no longer take place in the United States.) | ||
Performance Evaluation of BCG Vaccination in Healthcare Personnel to Reduce the Severity of SARS-COV-2 Infection in Medellín, Colombia, 2020[NCT04362124] | Phase 3 | 0 participants (Actual) | Interventional | 2020-08-31 | Withdrawn (stopped due to Study was stopped because Principal Investigator did not obtain sponsorship to carry it out) | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 review available for methanol and Infections, Staphylococcal
Article | Year |
---|---|
A case of delayed brain abscess due to a retained intracranial wooden foreign body: a case report and review of the last 20 years.
Topics: Adolescent; Brain Abscess; Female; Foreign Bodies; Frontal Lobe; Humans; Staphylococcal Infections; | 2004 |
18 other studies available for methanol and Infections, Staphylococcal
Article | Year |
---|---|
Antibacterial Effects of
Topics: Animals; Anti-Bacterial Agents; Collagen; Commiphora; Gentamicins; Male; Methanol; Mice; Plant Extra | 2022 |
Methanolic extract of Hemidesmus indicus root augments the antibacterial and antibiofilm activity of amoxicillin and clindamycin against methicillin-resistant Staphylococcus aureus of bovine origin.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Biofilms; Cattle; Clindamycin; Female; Hemidesmus; Meth | 2022 |
Topics: Animals; Anti-Bacterial Agents; Commiphora; Disease Models, Animal; Disk Diffusion Antimicrobial Tes | 2020 |
Phytochemical composition, anti-biofilm and anti-quorum sensing potential of fruit, stem and leaves of Salvadora persica L. methanolic extracts.
Topics: Anti-Bacterial Agents; Biofilms; Chromobacterium; Fruit; Indoles; Methanol; Microbial Sensitivity Te | 2017 |
Phytochemical analysis and antibacterial activity of methanolic extract of Bergenia purpurascens against common respiratory infection causing bacterial species in vitro and in neonatal rats.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antioxidants; Bacteria; Benzopyrans; Catec | 2018 |
In vitro antibacterial activity of Psidium guajava Linn. leaf extract on clinical isolates of multidrug resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Diffusion; Drug Resistance, Bacterial; Electrophoresis, Polyacrylamide Gel; E | 2008 |
Wound healing potential of methanol extract of Spathodea campanulata stem bark formulated into a topical preparation.
Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Bignoniaceae; Disease Models, Animal; Emoll | 2011 |
STUDIES ON THE HETEROLOGOUS IMMUNOGENICITY OF A MENTHANOL-INSOLUBLE FRACTION OF ATTENUATED TUBERCLE BACILLI (BCG). I. ANTIMICROBIAL PROTECTION.
Topics: Alcohols; Animals; Anti-Infective Agents; Bacillus; Immunity; Klebsiella; Methanol; Mice; Mycobacter | 1964 |
Antimicrobial evaluation of some plants used in Mexican traditional medicine for the treatment of infectious diseases.
Topics: Candidiasis; Colony-Forming Units Assay; Escherichia coli Infections; Medicine, Traditional; Methano | 1996 |
Effects of BCG, Corynebacterium parvum, and methanol-extration residue in the reduction of mortality from Staphylococcus aureus and Candida albicans infections in immunosuppressed mice.
Topics: Animals; Antineoplastic Agents; BCG Vaccine; Biological Products; Candida albicans; Candidiasis; Cyc | 1975 |
Effects of BCG, Corynebacterium parvum, and methanol-extration residue in the reduction of mortality from Staphylococcus aureus and Candida albicans infections in immunosuppressed mice.
Topics: Animals; Antineoplastic Agents; BCG Vaccine; Biological Products; Candida albicans; Candidiasis; Cyc | 1975 |
Effects of BCG, Corynebacterium parvum, and methanol-extration residue in the reduction of mortality from Staphylococcus aureus and Candida albicans infections in immunosuppressed mice.
Topics: Animals; Antineoplastic Agents; BCG Vaccine; Biological Products; Candida albicans; Candidiasis; Cyc | 1975 |
Effects of BCG, Corynebacterium parvum, and methanol-extration residue in the reduction of mortality from Staphylococcus aureus and Candida albicans infections in immunosuppressed mice.
Topics: Animals; Antineoplastic Agents; BCG Vaccine; Biological Products; Candida albicans; Candidiasis; Cyc | 1975 |
[Results of clinical trial of a new antibacterial preparation--dioxidine].
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Cyclic N-Oxides; Drug Resistance, Microbial; Female; | 1973 |
Molecular docking study of sappan wood extract to inhibit PBP2A enzyme on methicillin-resistant Staphylococcus aureus (MRSA).
Topics: Anti-Bacterial Agents; Bacterial Proteins; Computer Simulation; Humans; Methicillin-Resistant Staphy | 2020 |
The Efficiency of Biofilters at Mitigating Airborne MRSA from a Swine Nursery.
Topics: Air Filters; Air Microbiology; Animal Husbandry; Animals; Methicillin-Resistant Staphylococcus aureu | 2015 |
TWO VARIANTS OF STAPHYLOCOCCUS AUREUS WOOD 46 (NCTC 7121) DIFFERING IN RESPECT TO ALPHA TOXIN PRODUCTION.
Topics: Antitoxins; Staphylococcal Infections; Staphylococcus; Staphylococcus aureus; Toxins, Biological; Ty | 1963 |
[PRESENCE OF A 2D TOXIN, DIFFERENT FROM ALPHA HEMOLYSIN, IN CULTURE FILTRATES OF THE STAPHYLOCOCCUS AUREUS WOOD 46 STRAIN].
Topics: Animals; Chromatography; Electrophoresis; Erythrocytes; Hemolysin Proteins; Horses; Pharmacology; Ra | 1964 |
SEROLOGICAL TYPING OF STAPHYLOCOCCUS AUREUS. 6. ANTIBODIES OF IMMUNE SERA TO STRAINS COWAN I, COWAN II, COWAN III, WOOD 46, 670, 830, 1015, 5687, AND 6376.
Topics: Agglutination; Antibodies; Antitoxins; Immune Sera; Research; Staphylococcal Infections; Staphylococ | 1964 |
[STUDY OF A 2D HEMOLYSIN (DIFFERENT FROM ALPHA-HEMOLYSIN) PRESENT IN CULTURE FILTRATES OF THE WOOD 46 STRAIN OF STAPHYLOCOCCUS AUREUS (G OR DELTA HEMOLYSIN)].
Topics: Antitoxins; Bacterial Proteins; Chromatography; Hemolysin Proteins; Immunoelectrophoresis; Research; | 1965 |
[Wooden spike orbital injury].
Topics: Aged; Diagnosis, Differential; Enterobacteriaceae Infections; Female; Foreign Bodies; Humans; Magnet | 2005 |